Status:
COMPLETED
Situational Analysis of HIV-related Disability in the Context of Ivory Coast
Lead Sponsor:
Programme PAC-CI, Site ANRS-MIE de Côte d'Ivoire
Collaborating Sponsors:
Institute of Research for Development, France
Institut de Sante Publique, d'Epidemiologie et de Developpement
Conditions:
HIV Infections
Eligibility:
All Genders
40+ years
Brief Summary
The goal of this study is to document the impairment, functional and activity limitation and disability associated with HIV infection in an African urban context. It will combine quantitative and a q...
Detailed Description
Background With the scale up of antiretroviral therapy (ART), people living with HIV (PLWHIV) life expectancy has increased dramatically over the last decades and HIV has become a chronic disease. How...
Eligibility Criteria
Inclusion
- Age ≥40 years
- HIV-1 infection (or negative HIV test within the last 12 months if control)
- Ongoing antiretroviral treatment if HIV-infected participant
Exclusion
- Clinical symptoms suggesting an acute infection
- Any severe condition not allowing participation in the study
Key Trial Info
Start Date :
February 5 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 10 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05199831
Start Date
February 5 2021
End Date
August 10 2022
Last Update
February 8 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre National de Transfusion Sanguine
Abidjan, Côte d’Ivoire
2
CHU Treichville
Abidjan, Côte d’Ivoire